Keyphrases
Acute Myeloid Leukemia
100%
Autophagy
100%
FMS-like Tyrosine Kinase 3 (FLT3)
100%
Bruton's Tyrosine Kinase
100%
Inhibitor Resistance
100%
Aurora Kinase A (AURKA)
15%
Apoptosis
7%
Induced Apoptosis
7%
Leukemia
7%
Resistance Mechanisms
7%
Clinical Evaluation
7%
Hypoxia
7%
Cell Death
7%
Targeted Therapy
7%
Murine Model
7%
Clinical Activity
7%
Leukemia Cells
7%
Inhibitor Resistant
7%
Overcoming Resistance
7%
Mutation Status
7%
Double mutant
7%
G2-M Arrest
7%
Polyploidy
7%
Anti-leukemia
7%
Multikinase Inhibitor
7%
Strategies to Overcome
7%
Bone Marrow Microenvironment
7%
Co-target
7%
Patient-derived Xenograft
7%
Mechanistic Action
7%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Autophagy
100%
Bruton Tyrosine Kinase
100%
FMS-Like Tyrosine Kinase 3
100%
Programmed Cell Death
15%
Aurora Kinase
15%
Targeted Therapy
7%
Murine Leukemia
7%
Leukemia
7%
Xenograft
7%
Clinical Trial
7%
Cell Death
7%
Leukemia Cell
7%
Hypoxia
7%
Bone Marrow Microenvironment
7%
Polyploidy
7%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Protein Kinase Fer
100%
Bruton Tyrosine Kinase
100%
Leukemia
15%
Aurora Kinase
15%
Murine Leukemia
7%
Clinical Trial
7%
Hypoxia
7%